Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Montpellier, 34298, France
NCT Number: NCT00870415
RATIONALE: Breast-conserving surgery is a less invasive type of surgery for breast cancer and may have fewer side effects and improve recovery.
PURPOSE: This phase II trial is studying different breast-conserving surgery techniques in treating women with breast cancer.
Looking for future studies?
Notify Me18 year–120 year
Female
Interventional
Phase 2
Montpellier, 34298, France
OBJECTIVES:
Primary
Secondary
OUTLINE: This is a multicenter study.
Patients undergo oncoplastic conservative surgery according to defined modalities across the various centers.
Quality of life is assessed periodically.
After completion of study treatment, patients are followed every 6 months for 2 years and then for at least 3 years.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Time frame: From inclusion to end of intervention
Institut du Cancer de Montpellier - Val d'Aurelle
Other
Multicenter (Phase II) Study of Oncoplastic Surgical Techniques for Breast Conservation in Breast Cancers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05900986
Adenocarcinoma, Breast Cancer
Scottsdale, Arizona, United States
View Trial DetailsNCT02779855
Adenocarcinoma, Breast Cancer
Tampa, Florida, United States
View Trial DetailsNCT00898508
Adenocarcinoma, Breast Cancer
Beverly Hills, California, United States
View Trial DetailsNCT00182728
Adenocarcinoma, Breast Cancer
Chapel Hill, North Carolina, United States
View Trial Details